Transrectal biopsy
| Transrectal biopsy | |
|---|---|
| ICD-9-CM | 60.11 |
Transrectal biopsy is a biopsy procedure in which a sample of tissue is removed from the prostate using a thin needle that is inserted through the rectum and into the prostate.[1] Transrectal ultrasound (TRUS) is usually used to guide the needle.[2][3] The sample is examined under a microscope to see if it contains cancer.
References
[edit]- Transrectal biopsy entry in the public domain NCI Dictionary of Cancer Terms
This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.
 | This oncology article is a stub. You can help Wikipedia by expanding it. |
- ^ Moe, Andrew; Hayne, Dickon (December 2020). "Transrectal ultrasound biopsy of the prostate: does it still have a role in prostate cancer diagnosis?". Translational Andrology and Urology. 9 (6): 3018–3024. doi:10.21037/tau.2019.09.37. PMC 7807378.
- ^ Hodge, Kathryn K.; McNeal, John E.; Stamey, Thomas A. (July 1989). "Ultrasound Guided Transrectal Core Biopsies of the Palpably Abnormal Prostate". Journal of Urology. 142 (1): 66–70. doi:10.1016/S0022-5347(17)38663-9.
- ^ Smith, Joseph A. (October 1996). "Transrectal ultrasonography for the detection and staging of carcinoma of the prostate". Journal of Clinical Ultrasound. 24 (8): 455–461. doi:10.1002/(SICI)1097-0096(199610)24:8<455::AID-JCU5>3.0.CO;2-J. PMID 8884522.